BTK INHIBITORS
Clinical trials for BTK INHIBITORS explained in plain language.
Never miss a new study
Get alerted when new BTK INHIBITORS trials appear
Sign up with your email to follow new studies for BTK INHIBITORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to tame stubborn blood disorders
Disease control Not yet recruitingThis early-stage study tests whether combining two drugs (a CD20 antibody and a BTK inhibitor) can help people with refractory immune-related cytopenia—conditions where the immune system attacks blood cells, causing low platelets (ITP) or anemia (AIHA). About 30 adults aged 18-80…
Matched conditions: BTK INHIBITORS
Phase: PHASE1 • Sponsor: Qi deng • Aim: Disease control
Last updated May 09, 2026 05:18 UTC
-
Which cancer drug is safer for the heart? large study aims to find out
Knowledge-focused Not yet recruitingThis study looks at whether two similar cancer drugs, zanubrutinib and acalabrutinib, have different risks of causing an irregular heartbeat called atrial fibrillation. Researchers will analyze health records from 15,000 adults with chronic B-cell cancers. The goal is to help doc…
Matched conditions: BTK INHIBITORS
Sponsor: University Hospital, Caen • Aim: Knowledge-focused
Last updated May 04, 2026 16:20 UTC